A programmable platelet theranostic platform for adaptive multi-stage delivery and synergistic immunotherapy in atherosclerosis

Construction and characterization of Mn/TI@mHSA

Initially, HSA, a plasma protein characterized by low immunogenicity and intrinsic biocompatibility, was chosen as the protein carrier for loading both nanocatalysts and TRAF6 signaling inhibitor. To…

Continue Reading